文献速递肿瘤 PET/CT核素与放射性配体治疗

基因组学、分子影像与治疗在胃肠道肿瘤中的相互作用

The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.
PubMed 文献 · Semin Nucl Med · 2020-07-09

本文综述了胃肠道肿瘤的分子遗传学进展,包括驱动突变、抑癌基因失活和DNA修复受损等机制,以及乙肝、丙肝和HPV感染与肝癌和肛管癌的关联。基因组知识有助于界定结肠癌和胰腺癌等疾病的独特亚群以接受精准靶向治疗,肿瘤关键蛋白和微环境改变可作为分子靶向放射性药物、免疫治疗等靶点。分子影像可更积极用于高危人群的肿瘤发生、进展和治疗反应检测。

要点

  • 胃肠道肿瘤发生涉及驱动突变、抑癌基因失活和DNA修复受损等基因组改变。
  • 乙肝/丙肝和HPV感染分别与肝细胞癌和肛管癌相关。
  • 分子影像可评估肿瘤表型,辅助高危人群检测和管理。

核心结论

  • 基因组学、分子影像与靶向治疗在胃肠道肿瘤管理中相互关联,分子影像可评估肿瘤表型并辅助临床决策。

研究设计与样本

  • 本文为综述,总结了胃肠道肿瘤的基因组学、靶向治疗示例以及当前和新兴分子影像工具的应用。

主要发现

  • 过去20年对胃肠道肿瘤分子遗传学认识取得巨大进展,癌症发展源于驱动突变、抑癌基因失活和DNA修复受损。
  • 乙肝和丙肝感染可导致肝细胞癌,HPV感染可导致肛管癌。
  • 基因组知识有助于界定结肠癌和胰腺癌等疾病的独特亚群,可能受益于精准靶向治疗。
  • 肿瘤关键蛋白和肿瘤微环境改变可作为分子靶向放射性药物、免疫治疗等靶点。
  • 分子影像可更积极用于高危人群检测肿瘤发生、进展和治疗反应。

临床怎么用

  • 利用基因组知识识别胃肠道肿瘤独特亚群,指导精准靶向治疗选择。
  • 对高危人群更积极应用分子影像检测肿瘤发生、进展和治疗反应。
  • 基于肿瘤关键蛋白和微环境改变选择分子靶向放射性药物或免疫治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the past 20 years there have been great advances in our understanding of the molecular genetics of gastrointestinal tumors. In general, cancers develop and proliferate due to: driver mutations or related alterations in the genome resulting in overactivity of oncogenes, underactivity of tumor suppressor genes allowing tumors to grow, and impaired DNA repair mechanisms either from sequential mutations with or without germline mutations predisposing patients to cancer. Infections such as hepatitis B and C, and Human Papilloma Virus (HPV) can lead to hepatocellular cancers and anal cancers, respectively. This genomic knowledge has helped us better define unique subsets within diseases like colon and pancreatic cancer which may benefit from precisely targeted therapies. Alterations in key proteins on tumors and in the tumor microenvironment can be targets for molecular-targeted radiopharmaceutical therapies, immunotherapies and other targeted treatments. Molecular imaging may be deployed more aggressively in high-risk groups for possible detection of tumor occurrence, progression, and response to therapy. This chapter provides a brief summary of the genomics of gastrointestinal tumors, selected examples of targeted therapies, and examples of how current and emerging molecular imaging tools, assessing the tumor phenotype, inform our management of patients with tumors.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wahl RL. The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors. Semin Nucl Med. 2020. PMID: 32768010. doi:10.1053/j.semnuclmed.2020.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。